Ernexa Therapeutics Inc. ERNA NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score

40/100

0/4 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Ernexa Therapeutics Inc. (ERNA) has a negative trailing P/E of -0.1, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -874.26%.

Criteria proven by this page:

VALUE (0/100, Fail) — negative P/E indicates the company is currently operating at a loss — DCF and P/E-based valuation models cannot produce meaningful results for unprofitable companies (P/E -0.1); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY -874.26%).
Trailing Earnings Yield -874.26% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.

Overall SharesGrow Score: 36/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

40/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

HEALTH

50/100

Debt-to-Equity & liquidity

→ Health

MOAT

50/100

→ Income

GROWTH

58/100

→ Income

—

INCOME

N/A

No coverage

Valuation Snapshot — ERNA

Valuation Multiples

P/E (TTM)-0.1

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.67

P/S Ratio0.00

EV/EBITDA0.0

Per Share Data

EPS (TTM)$-1.79

Book Value / Share$0.31

Revenue / Share$0.00

FCF / Share$-0.90

Yields & Fair Value

Earnings Yield-874.26%

Dividend Yield0.00%

Historical Valuation

Year	P/E (TTM)	PEG Ratio	P/B Ratio	P/S Ratio	Dividend Yield
2016	-83.0	1.36	59.64	10.87	0.01%
2017	-143.2	2.01	27.86	7.25	0.01%
2018	-303.6	3.88	11.37	3.37	0.02%
2019	-46.3	-0.07	18.64	4.79	0.02%
2020	195.6	-2.23	304.08	0.00	-
2021	-22.1	-0.01	106.20	0.00	0.00%
2022	-6.0	0.07	12.17	0.00	0.01%
2023	-6.6	0.13	64.25	2,109.97	0.01%
2024	-2.8	0.05	73.62	215.18	-
2025	-0.5	-0.01	3.15	0.00	-

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2016	$-61.44	$22.31M	$-2.92M	-13.1%
2017	$-17.64	$21.27M	$-1.08M	-5.1%
2018	$-3.85	$23.34M	$-259K	-1.1%
2019	$-28.48	$19.81M	$-2.05M	-10.3%
2020	$27.08	$0.00	$11.91M	-
2021	$-56.49	$0.00	$-122.31M	-
2022	$-8.06	$0.00	$-24.58M	-
2023	$-4.08	$68K	$-21.67M	-31864.7%
2024	$-3.26	$582K	$-44.54M	-7652.7%
2025	$-2.24	$0.00	$-14.1M	-